The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Pathophysiology of sepsis-induced cardiomyopathy

SM Hollenberg, M Singer - Nature Reviews Cardiology, 2021 - nature.com
Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to
infection and is the leading cause of death in intensive care units. Cardiac dysfunction …

International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology

JR Ghadri, IS Wittstein, A Prasad… - European heart …, 2018 - academic.oup.com
Takotsubo syndrome (TTS) is a poorly recognized heart disease that was initially regarded
as a benign condition. Recently, it has been shown that TTS may be associated with severe …

Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review

AR Lyon, R Citro, B Schneider, O Morel… - Journal of the American …, 2021 - jacc.org
Takotsubo syndrome (TTS) has been a recognized clinical entity for 31 years, since its first
description in 1990. TTS is now routinely diagnosed in patients who present with acute chest …

Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review

H Medina de Chazal, MG Del Buono… - Journal of the American …, 2018 - jacc.org
Stress cardiomyopathy is an acute reversible heart failure syndrome initially believed to
represent a benign condition due to its self-limiting clinical course, but now recognized to be …

Immune checkpoint inhibitors and cardiovascular toxicity

AR Lyon, N Yousaf, NML Battisti, J Moslehi… - The Lancet …, 2018 - thelancet.com
Immune checkpoint inhibitors are a new class of anticancer therapies that amplify T-cell-
mediated immune responses against cancer cells. Immune checkpoint inhibitors have …

Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association

B Bozkurt, M Colvin, J Cook, LT Cooper, A Deswal… - Circulation, 2016 - ahajournals.org
The first classification on this topic categorized cardiomyopathies as heart muscle diseases
with dilated (DCM), hypertrophic, restrictive, arrhythmogenic right ventricular (ARVC), or …

Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European …

AR Lyon, E Bossone, B Schneider… - European journal of …, 2016 - Wiley Online Library
Takotsubo syndrome is an acute reversible heart failure syndrome that is increasingly
recognized in modern cardiology practice. This Position Statement from the European …

Takotsubo syndrome: a review of presentation, diagnosis and management

J Assad, G Femia, P Pender, T Badie… - Clinical Medicine …, 2022 - journals.sagepub.com
Takotsubo Syndrome (TTS) is a condition of transient left ventricular dysfunction that is
typically triggered by emotional or physical stress. Since first described in Japan in 1990, it …

Adrenergic nervous system in heart failure: pathophysiology and therapy

A Lymperopoulos, G Rengo, WJ Koch - Circulation research, 2013 - ahajournals.org
Heart failure (HF), the leading cause of death in the western world, develops when a cardiac
injury or insult impairs the ability of the heart to pump blood and maintain tissue perfusion. It …